This site is intended for U.S. healthcare professionals.

Visit Pfizer Medical

Menu

Close

Sign InLog OutTherapy AreasProductsOrder VaccinesOrder SamplesOrderMaterialsCo-pay Cards & Patient Savings OffersRequest SamplesHospital ProductsVaccinesPatient AssistancePfizer Oncology TogetherPfizer RxPathwaysPfizer Dermatology Patient AccessExplore ContentEventsMaterialsVideosContact

Menu

Close

AcutePreventiveSafetyDosingDosingDosingMOASavings & SupportSavings
& SupportSavings & SupportFormulary CoverageResourcesResourcesProvider & Patient EducationPrior Authorization
Prescribing InformationIndicationsPatient InformationPatient Site
Formulary coverage lookup tool
Find Nurtec ODT coverage information in your area
*Some plans may not display due to health plan–specific policy.
The information provided is not a guarantee of coverage or payment (partial or full) and is subject to change without notice.
† Eligible commercially insured patients can, for one time only, access Nurtec ODT at no cost while benefits are being verified for one prescription fill, with a maximum of 16 tablets total. Insurance coverage must be approved by the payor for patients to continue receiving Nurtec ODT with no out-of-pocket cost. No membership fees. Only available for commercially insured patients. This is not health insurance. Maximum annual benefit of $7,000 applies. The full terms and conditions can be accessed at nurtec.com/terms-and-conditions.
Access and enrollment based on MMIT formulary information as of [EFFECTIVE_DATE] and represents the local area, based on the first three digits of the ZIP code.
Access based on MMIT formulary information as of [EFFECTIVE_DATE].
*Some plans may not display due to health plan–specific policy.
The information provided is not a guarantee of coverage or payment (partial or full) and is subject to change without notice.
‡Majority of plans require Prior Authorization.
While Pfizer strives to make this information as timely and accurate as possible, it makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of the contents, and expressly disclaims liability for errors and omissions in the contents. Pfizer does not guarantee coverage of insured benefits; all benefits are subject to the insured's plan requirements. Please consult the health plan directly for comprehensive policy information. Reference in this information to any specific payor plan does not constitute endorsement, recommendation or favoring by Pfizer and inclusion in a medical policy does not imply comparable or superior efficacy/safety of drug products.
Sources: Managed Markets Insight & Technology, LLC, database since January 2025. IQVIA database as of May 2025.
†Eligible commercially insured patients can, for one time only, access Nurtec ODT at no cost while benefits are being verified for one prescription fill, with a maximum of 16 tablets total. Insurance coverage must be approved by the payor for patients to continue receiving Nurtec ODT with no out-of-pocket cost. No membership fees. Only available for commercially insured patients. This is not health insurance. Maximum annual benefit of $7,000 applies. The full terms and conditions can be accessed at nurtec.com/terms-and-conditions.
[LEVEL_MESSAGE]
Find Nurtec ODT coverage information in your area
*Some plans may not display due to health plan–specific policy.
The information provided is not a guarantee of coverage or payment (partial or full) and is subject to change without notice.
†Eligible commercially insured patients can, for one time only, access Nurtec ODT at no cost while benefits are being verified for one prescription fill, with a maximum of 16 tablets total. Insurance coverage must be approved by the payor for patients to continue receiving Nurtec ODT with no out-of-pocket cost. No membership fees. Only available for commercially insured patients. This is not health insurance. Maximum annual benefit of $7,000 applies. The full terms and conditions can be accessed at nurtec.com/terms-and-conditions.
Access and enrollment based on MMIT formulary information as of [EFFECTIVE_DATE] and represents the local area, based on the first three digits of the ZIP code.
Access based on MMIT formulary information as of [EFFECTIVE_DATE].
*Some plans may not display due to health plan–specific policy.
The information provided is not a guarantee of coverage or payment (partial or full) and is subject to change without notice.
‡Majority of plans require Prior Authorization.
While Pfizer strives to make this information as timely and accurate as possible, it makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of the contents, and expressly disclaims liability for errors and omissions in the contents. Pfizer does not guarantee coverage of insured benefits; all benefits are subject to the insured's plan requirements. Please consult the health plan directly for comprehensive policy information. Reference in this information to any specific payor plan does not constitute endorsement, recommendation or favoring by Pfizer and inclusion in a medical policy does not imply comparable or superior efficacy/safety of drug products.
Sources: Managed Markets Insight & Technology, LLC, database since January 2025. IQVIA database as of May 2025.
†Eligible commercially insured patients can, for one time only, access Nurtec ODT at no cost while benefits are being verified for one prescription fill, with a maximum of 16 tablets total. Insurance coverage must be approved by the payor for patients to continue receiving Nurtec ODT with no out-of-pocket cost. No membership fees. Only available for commercially insured patients. This is not health insurance. Maximum annual benefit of $7,000 applies. The full terms and conditions can be accessed at nurtec.com/terms-and-conditions.
[LEVEL_MESSAGE]
Have samples of Nurtec ODT delivered to your officeGet samplesLoadingGet the details on savings and supportPatients may be able to save with the Nurtec ODT savings card.† Get savings information Loading

To report an adverse event, please call 1-800-438-1985

Pfizer for Professionals 1-800-505-4426

This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.

© 2025 Pfizer Inc. All rights reserved.

PP-NNT-USA-4379
INDICATIONSNurtec ODT is indicated in adults for the:
  • acute treatment of migraine with or without aura
  • preventive treatment of episodic migraine

Please click here for full Prescribing Information.
Important Safety Information Contraindications: Hypersensitivity to Nurtec ODT or any of its components. Warnings and Precautions Hypersensitivity Reactions: If a serious hypersensitivity reaction occurs, discontinue Nurtec ODT and initiate appropriate therapy. Serious hypersensitivity reactions have included anaphylaxis, dyspnea, and rash and can occur days after administration. Hypertension: Development of hypertension and worsening of pre-existing hypertension have been reported following the use of CGRP antagonists, including Nurtec ODT, in the postmarketing setting.Monitor patients for new-onset hypertension or worsening of pre-existing hypertension and consider whether discontinuation is warranted. Raynaud’s Phenomenon: Development of Raynaud’s phenomenon and recurrence or worsening of pre-existing Raynaud’s phenomenon have been reported in the postmarketing setting following the use of CGRP antagonists, including Nurtec ODT.If signs or symptoms of Raynaud’s phenomenon develop, discontinue Nurtec ODT. Patients should be evaluated by a healthcare provider if symptoms do not resolve. Patients with a history of Raynaud’s phenomenon should be monitored for and informed about the possibility of worsening or recurrence of signs and symptoms. Adverse Reactions: The most common adverse reactions for Nurtec ODT vs placebo were nausea (2.7% vs 0.8%) and abdominal pain/dyspepsia (2.4% vs 0.8%). Drug Interactions: Avoid concomitant administration of Nurtec ODT with strong inhibitors of CYP3A4 or strong or moderate inducers of CYP3A. Avoid another dose of Nurtec ODT within 48 hours when it is administered with moderate inhibitors of CYP3A4 or potent inhibitors of P-gp. Use in Specific Populations: Pregnancy: It is not known if Nurtec ODT can harm an unborn baby.
Lactation: The transfer of rimegepant into breast milk is low (<1%). Hepatic impairment: Avoid use of Nurtec ODT in persons with severe hepatic impairment. Renal impairment: Avoid use in patients with end-stage renal disease.IndicationsNurtec ODT is indicated in adults for the:
  • acute treatment of migraine with or without aura
  • preventive treatment of episodic migraine

Please click here for full Prescribing Information.